CD1A and neoplasm: Unexpectedly, the CD1a-high group showed unfavorable clinical outcomes and it was an independent prognostic factor in multivariate analyses which involved TMN staging, whereas tumor-infiltrating S100+ DCs were not significantly associated with clinical outcomes.